A clinical review of drug-induced gingival overgrowths

Australian Dental Journal

Volumn 44, Issue 4, 1999, Pages 219-232

  Marshall, Roderick I ^a   Bartold, P Mark ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

Calcium channel blockers; Cyclosporin; Gingival overgrowth; Phenytoin

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PHENYTOIN;

AUSTRALIA; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; GINGIVA OVERGROWTH; HUMAN; MOUTH HYGIENE; REVIEW;

ANTICONVULSANTS; AUSTRALIA; CALCIUM CHANNEL BLOCKERS; CYCLOSPORINE; DRUG INTERACTIONS; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORAL HYGIENE; PHENYTOIN;

EID: 0033256363     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.1999.tb00224.x     Document Type: Review

References (104)

1. Adverse Drug Reaction Advisory Committee. Drug induced gingival overgrowth. Australian Adverse Drug Reactions Bulletin 1999;18:6-7.
2. Lokken P, Skomedal T. Gingival hyperplasia induced by calcium channel blockers. Rare or frequent in Norway? Tidsskr Nor Laegeforen 1992;112:1978-1980.
3. Kimball O. The treatment of epilepsy with sodium diphenylhydantoinate. JAMA 1939;112:1244-1245.
4. Hassell T. Epilepsy and the oral manifestations of phenytoin therapy Basel: Karger, 1983.
5. Thomason J, Seymour R, Rawlins M. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice. Community Dent Oral Epidemiol 1992;20: 288-291.
6. Hassell T, O'Donnell J, Pearlman J, Tesini D, Murphy T, Best H. Phenytoin-induced gingival overgrowth in institutionalised epileptics. J Clin Periodontol 1984;11:242-253.
7. Darling M, Arendorf T, Shaikh A, Stephen L. Gingival hyperplasia of an edentulous alveolar ridge in an epileptic - a case report. N Z Dent J 1988;84:114-116.
8. McCord J, Sloan P, Quayle A, Hussey D. Phenytoin hyperplasia occurring under complete dentures: a clinical report. J Prosthet Dent 1992;68:569-572.
9. Peñarrocha-Diago M, Bagán-Sebastián J, Vera-Sempere F. Diphenylhydantoin-induced gingival overgrowth in man: A clinico-pathological study. J Periodontol 1990;61:571-574.
10. Panuska H, Gorlin R, Bearman J, Mitchell D. The effect of anticonvulsant drugs upon the gingiva - a series of analyses of 1048 patients II. J Periodontol 1961;31:15-28.
11. Addy V, McElnay J, Eyre D, Campbell N, D'Arcy P. Risk factors in phenytoin-induced gingival hyperplasia. J Periodontol 1983;54:373-377.
12. Steinberg S, Steinberg A. Phenytoin-induced gingival overgrowth in severely retarded children. J Periodontol 1982;53:429-433.
13. Pihlstrom B, Carson J, Smith Q, Bastien S, Keenan K. Prevention of phenytoin associated gingival enlargement - a 15 month longitudinal study. J Periodontol 1980;51:311-317.
14. Modéer T, Dahllöf G. Development of phenytoin induced gingival overgrowth in non-institutionalised epileptic children subject to different plaque control programs. Acta Odontol Scand 1987;45:81-85.
15. Seymour R. Drug-induced gingival overgrowth. Adverse Drug ReactToxicol Rev 1993;12:215-232.
16. Hassell T, Gilbert G. Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am J Pathol 1983;112:218-223.
17. Hassell T, Page R, Lindhe J. Histologic evidence for impaired growth control in diphenylhydantoin gingival overgrowth in man. Arch Oral Biol 1978;23:381-384.
18. Goultschin J, Shoshan S. Inhibition of collagen breakdown by diphenylhydantoin. Biochim Biophys Acta 1980;631:188-191.
19. May L, Tan E, Holness R, Vitto J. Phenytoin modulates connective tissue metabolism and cell proliferation in human skin fibroblast cultures. Arch Dermatol 1985;121:79-83.
20. Kantor M, Hassell T. Increased accumulation of sulfated glycosaminoglycans in cultures from human fibroblasts from phenytoin-induced gingival overgrowth. J Dent Res 1983;62:383-387.
21. Suresh R, Puvanakrishnan R, Dhar S. Alterations in human gingival glycosaminoglycan pattern in inflammation and phenytoin induced overgrowth. Mol Cell Biochem 1992;115:149-154.
22. 2+ accumulation in gingival fibroblasts in vitro. J Oral Pathol Med 1989;18:485-489.
23. Marshall R, Bartold P. Medication induced gingival overgrowth. Oral Dis 1998;4:130-151.
24. Modéer T, Dahllöf G, Karsten J, Otteskog P. Potentiation of fibroblast DNA synthesis by a phenytoin-induced mononuclear cell derived factor in vitro. Scand J Dent Res 1989;87:186-187.
25. Dill R, Miller E, Weil T, Lesley S, Farmer G, Lacopino A. Phenytoin increases gene expression for platelet derived growth factor B chain in macrophages and monocytes. J Periodontol 1993;64:169-173.
26. 19 steroid conversions in fibroblasts. J Periodontol 1997;68:819-826.
27. Inoue F, Harrison J. Folic acid and phenytoin hyperplasia. Lancet 1981;2:86.
28. Poppell T, Keeling S, Collins F, Hassell T. Effect of folic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy. J Clin Periodontol 1991;18:134-139.
29. Seymour R, Heasman P. Drugs, diseases, and the periodontium. Oxford: Oxford University Press, 1992.
30. Seymour R, Smith D, Turnball D. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptics. J Clin Periodontol 1985;12:413-419.
31. Syrjanen S, Syrjanen K. Hyperplastic gingivitis in a child receiving sodium valproate. Proc Finn Dent Soc 1979;75:95-98.
32. Behari M. Gingival hyperplasia due to sodium valproate. J Neurol Neurosurg Psychiatry 1991;45:279-280.
33. Gregoriou A, Schneider P, Shaw P. Phenobarbital-induced gingival overgrowth? Report of two cases and complications in management. J Dent Child 1996;63:408-413.
34. Katz J, Givol N, Chaushu G, Taicher S, Shemer J. Vigabatrin-induced gingival overgrowth. J Clin Periodontol 1997;24:180-182.
35. Calne R, Thiru S, McMaster P, et al. Cyclosporin-A in patients receiving renal allografts from cadaver donors. Lancet 1978;1:1323-1327.
36. Starzl T, Weil R, Iwatsuki S, et al. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980;151:17-26.
37. Rateitschak-Plüss E, Hefti A, Lörtscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
38. Calne R, Rolles K, White D, et al. Cyclosporin-A in clinical organ grafting.Transpl Proc 1981;13:349-358.
39. Wysocki G, Gretzinger H, Laupacis A, Ulan R, Stiller C. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
40. Tyldesley W, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
41. Wondimu B, Dahllöf G, Berg U, Modéer T. Cyclosporin-A-induced gingival overgrowth in renal transplant children. Scand J Dent Res 1993;101:282-286.
42. Friskopp J, Klintman G. Gingival enlargement. A comparison between cyclosporine and azothioprine treated renal allograft recipients. Swed Dent J 1986;10:85-92.
43. Seymour R, Jacobs D. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
44. Daley T, Wysocki G, Day C. Clinical and pharmacological correlations in cyclosporin-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-421.
45. Modéer T, Wondimu B, Larsson E, Jonzon B. Levels of cyclosporin-A (CsA) in saliva in children after oral administration of the drug in mixture or in capsule form. Scand J Dent Res 1992;100:366-370.
46. Seymour R, Smith D, Rogers S. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. J Clin Periodontol 1987;14:610-613.
47. The Multiple Sclerosis Study Group. Efficacy and toxicity of cylosporine in chronic progressive multiple sclerosis: A randomized, double blinded, placebo controlled clinical trial. Ann Neurol 1990;27:591-605.
48. Thomason J, Seymour R, Ellis J, Kelly P, Parry G, Dark J, Idle J. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
49. Karpinia K, Matt M, Fennell R III, Hefti A. Factors affecting cyclosporine-induced gingival overgrowth in pediatric renal transplant recipients. Pediatr Dent 1996;18:450-455.
50. Niimi A, Tohnai I, Kaneda T, Takeuchi M, Nagura H. Immunohistochemical analysis of the effects of cyclosporin A on gingival epithelium. J Oral Pathol Med 1990;19:397-403.
51. Seymour R, Smith D. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
52. Thomason J, Kelly P, Seymour R. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996;23:367-371.
53. Bartold P. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodont Res 1989;24:314-321.
54. Barber M, Savage N, Seymour G. The effect of cyclosporin and lipopolysaccharide on fibroblasts: Implications for cyclosporin-induced gingival overgrowth. J Periodontol 1992;63:397-404.
55. Tipton D, Stricklin G, Dabbous M. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46:152-165.
56. Thomason J, Seymour R, Ellis J, et al. Determinants of gingival overgrowth severity in organ transplant patients: An examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628-634.
57. Cebeci I, Kantarci A, Firatli E, et al. Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A. J Clin Periodontol 1996;23:737-742.
58. Thomson W, Slade G, Spencer A. Dental caries experience and use of prescription medications among people aged 60+ in South Australia. Gerodontology 1995;12:104-110.
59. Lederman D, Lumerman H, Reuban S, Freeman P. Gingival hyperplasia associated with nifedipine therapy. Oral Surg Oral Med Oral Pathol 1984;57:620-622.
60. Ramon Y, Behar S, Kishon Y, Engelberg I. Gingival hyperplasia caused by nifedipine - a preliminary report. Int J Cardiol 1984;5:195-204.
61. Cucchi G, Giustiniani S, Robustelli F. Gengivite ipertrofica da verapamil. (Gingival hyperplasia caused by verapamil.) G Ital Cardiol 1985;15:556-557.
62. Colvard M, Bishop J, Weissman D, Bargiulo A. Cardizem-induced gingival hyperplasia. Periodontal Case Rep 1986;8:67-68.
63. Barak S, Engelberg I, Hiss Z. Gingival hyperplasia caused by nifedipine: histopathological findings. J Periodontol 1987;58:639-642.
64. Fattore L, Stablein M, Bredfelt G, Semla T, Moran M, Doherty-Greenburg J. Gingival hyperplasia: a side effect of nifedipine and diltiazem. Spec Care Dent 1991;11:107-109.
65. Barclay S, Thomason J, Idle J, Seymour R. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992;19:311-314.
66. Nervy E, Edson R, Lee K, Pruthi K, Watson J. Prevalence of nifedipine-induced gingival hyperplasia. J Periodontol 1995;66:572-578.
67. Ellis J, Seymour R, Monkman S, Idle J. Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowth. J Periodontal Res 1993;28:373-378.
68. Harel-Raviv M, Eckler M, Lalani K, Raviv E, Gornitsky M. Nifedipine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1995;79:715-722.
69. Miller C, Damm D. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992;63:453-456.
70. Giustiniani S, Robustelli della Cuna F, Marieni M. Hyperplastic gingivitis during diltiazem therapy. Int J Cardiol 1987;15:247-249.
71. Ellis J, Seymour R, Thomason J, Monkman S, Idle J. Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. (Letter.) Lancet 1993;341:1102-1103.
72. Jorgensen M. Prevalence of amlodipine-related gingival hyperplasia. J Periodontol 1997;68:676-678.
73. Seymour R, Ellis J, Thomason J, Monkman S, Idle J. Amlodipine-induced gingival overgrowth. J Clin Periodontol 1994;21:281-283.
74. Lombardi T, Fiore Donno G, Belser U, Di Felice R. Felodipine induced gingival hyperplasia: a clinical and histologic study. J Oral Pathol Med 1991;20:89-92.
75. Young P, Turiansky G, Sau P, Liebman M, Benson P. Felodipine induced gingival hyperplasia. Cutis 1998;62:41-43.
76. Glefand E, Cheung R, Grinstein S, Mills G. Characterization of the role of calcium influx in mitogen-induced triggering of human T cells. Identification of calcium-dependent and calcium independent signals. Eur J Immunol 1986;16:907-912.
77. Sooriyamoorthy M, Gower D, Eley B. Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990;25:25-30.
78. Saito K, Mori S, Iwakura M, Sakamoto S. Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia. J Periodont Res 1996;31:545-555.
79. Mehta A, Chidambaram B, O'Riordan A. Verapamil-induced gingival hyperplasia in children. Am Heart J 1992;124:535-536.
80. Valsecchi R, Cainelli T. Gingival hyperplasia induced by erythromycin. Acta Derm Venereol (Stockh) 1992;72:157.
81. Brunsvold M, Tomasovic J, Reumping D. The measured effect of phenytoin withdrawal on gingival hyperplasia in children. J Dent Child 1985;13:845-849.
82. Dahllöf G, Axiö E, Modéer T. Regression of phenytoin-induced gingival overgrowth after withdrawal of medication. Swed Dent J 1991;15:139-143.
83. Daly C. Resolution of cyclosporin A (CsA)-induced gingival enlargement following reduction in CsA dosage. J Clin Periodontol 1992;19:143-145.
84. Budde K, Fritsche L, Mai I, et al. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation. Int J Clin Pharm Ther Toxicol 1996;34:493-497.
85. Puolijoki H, Siitonen L, Saha H, Suojanen I. Gingival hyperplasia caused by nifedipme. Proc Finn Dent Soc 1988;84:311-314.
86. Westbrook P, Bednarczyk E, Carlson M, Sheehan H, Bissada N. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. J Periodontol 1997;68:645-650.
87. Ciancio S, Bartz N, Lauciello F. Cyclosporine-induced gingival hyperplasia and chlorhexidine: A case report. Int J Periodontics Restorative Dent 1991;11:241-245.
88. Pilatti G, Sampaio J. The influence of chlorhexidine on the severity of cylocposin A-induced gingival overgrowth. J Periodontol 1997;68:900-904.
89. Pernu H, Pernu L, Huttunen K, Nieminen P, Knuuttila M. Gingival overgrowth among renal allograft recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
90. Bullon P, Machuca G, Martinezsahuquillo A, Rios J, Velasco E, Rojas J, Lacalle J. Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem. J Clin Periodontol 1996;23:649-657.
91. Hancock R, Swan R. Nifedipine-induced gingival hyperplasia. J Clin Periodontol 1992;19:12-14.
92. Zlotogorski A, Nyska M, Sela M, Nyska A, Gotsman M. Nifedipine-induced gingival hyperplasia: Case reports and literature review. Isr J Med Sei 1989;25:453-455.
93. 2 laser in the excision of gingival hyperplasia caused by nifedipine. J Clin Periodontol 1988;15:633-635.
94. Pernu H, Oikarinen K, Hietanen J, Knuuttila M. Verapamil-induced gingival overgrowth: a clinical, histologic, and biochemic approach. J Oral Pathol Med 1989;18:422-425.
95. 2 laser for the removal of phenytoin hyperplasia. J Periodontol 1985;56:492-496.
96. 2 laser for gingivectomy in a patient with Sturge-Weber disease complicated by dilantin hyperplasia. J Oral Maxillofac Surg 1986;44:646-648.
97. Abitbol T, Rosenfeld-Abitbol M. Surgical treatment of nifedipine-induced gingival hyperplasia. A case report. N Y State Dent J 1996;62:34-37.
98. Nishikawa S, Tada H, Hamasaki A, et al. Nifedipine-induced gingival hyperplasia: A clinical and in vitro study. J Periodontol 1991;62:30-35.
99. Bowman J, Levy B, Grubb R. Gingival overgrowth induced by diltiazem. Oral Surg Oral Med Oral Pathol 1988;65:183-185.
100. Slavin J, Taylor J. Cyclopsporin, nifedipine and gingival hyperplasia. Lancet 1987;2:739.
101. Margiotta V, Pizzo I, Barbaro A. Cyclosporin and nifedipine induced gingival overgrowth in renal transplant patients: Correlations with periodontal and pharmacological parameters, and HLA antigens. J Oral Pathol Med 1996;25:128-134.
102. Thomason J, Seymour R, Rice N. The prevalence and severity of cyclosporin and nifedipine induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
103. Cebeci I, Kantarci A, Firatli E, Carin M, Tuncer Ȯ. The effect of verapamil on the prevalence and severity of cyclosporine-induced gingival overgrowth in renal allograft recipients. J Periodontol 1996;67:1201-1205.
104. Seymour R, Thomason R, Ellis J. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.